Quidel to acquire Ortho Clinical Diagnostics for $6 billion

Quidel Corporation signed a definitive agreement to acquire Ortho Clinical Diagnostics for $24.68 per share, representing an equity value of approximately $6.0 billion. The transaction is expected to close in the first half of fiscal year 2022.

“The combination with Ortho will help solidify Quidel as a leader in the diagnostics industry, bringing together innovative, complementary products, solutions, and services that enhance the health and well-being of patients across the globe.”quidelortho.com

• 1 source
• quidelortho.comQuidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics | QuidelOrthoDec 22, 2021

Summarized from public sources; check the original articles before acting on it.